Board of Directors 2021-2022
Isao Kamae, DrPH, MD,
Project Professor, Health Policy and Technology Assessment, University of Tokyo, Graduate School of Public Policy
Tokyo, Japan
Jens Grueger, PhD
Director and Partner
Boston Consulting Group
Zurich, Switzerland
President Elect (2021-2022)
Jan Elias Hansen, PhD
Vice President, Evidence for Access Unit - Genentech’s US Medical Affairs
Director (2021-2024)
Beth Devine, PhD
Professor, Graduate program director, The Comparative Heath Outcomes, Policy and Economics (CHOICE) Institute, School of Pharmacy, University of Washington (UW)
Director (2021-2024)
Marlene Gyldmark, MPhil
Lead, HEOR and Real-World Data Group, Roche Diabetes Care
Director (2021-2024)
Andrea Manca, MSc PhD
Professor, Centre for Health Economics at the University of York
Biography and Vision Statement
Director (2020-2023)
Eberechukwu Onukwugha, PhD
Associate Professor, University of Maryland
Baltimore, MD, USA
Director (2021-2023)
Lotte Steuten, MPhil
Vice-President and Head of Consulting at the Office of Health Economics and Honorary Visiting Professor at City, University of London, UK
Director (2021-2024)
Dong-Churl Suh, PhD
Professor and Director of the Graduate Program at the Chung-Ang University College of Pharmacy in Seoul, Korea
Director (2020-2023)
David Thompson, PhD
Chief Executive Officer, Open Health Evidence & Access
Boston, MA, USA
Treasurer (2020-2023)
Sean D. Sullivan, BScPharm, MSc, PhD,
Professor and Dean, University of Washington, School of Pharmacy
CEO & Executive Director
Nancy S. Berg
CEO & Executive Director
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, NJ, USA